Sign In
Buy INCY
$119.80
-0.800 (-0.663%)
At Close: Aug 05, 2026
Initial data from a pair of clinical trials may revive interest in arthritis drugs as COVID-19 treatments
07:48pm, Friday, 18'th Sep 2020
There is some renewed hope for rheumatoid arthritis drugs like Eli Lilly’s Olumiant and Roche’s Actemra as possible COVID-19 treatments after a series of...
Incyte FDA Approvals To Propel Future Growth (NASDAQ:INCY)
05:28pm, Friday, 18'th Sep 2020
Baricitinib/Olumiant COVID-19 results a plus. Pemazyre and other recent approvals should accelerate growth.
The number of confirmed cases of the coronavirus that causes COVID-19 rose above 30 million on Friday, and the death toll rose above 946,000, with the U.S....
Shares of Roche gain as it says arthritis drug can lessen need for ventilators in COVID-19 patients
11:42am, Friday, 18'th Sep 2020
Shares of Roche Holding AG undefined gained 1.9% in premarket trading on Friday after the drug maker said hospitalized COVID-19 patients taking rheumatoid...
Encouraging Results from Phase 2 Trial of Retifanlimab in Patients with Previously Treated, Advanced Squamous Cell Carcinoma of the Anal Canal
Analyst and investor conference call and webcast scheduled for Tuesday, September 29, 2020 at 9:00 a.m. EDT / 3:00 p.m. CEST PLANEGG/MUNICH and WILMINGTON, DE / ACCESSWIRE / September 17, 2020 / Morph
Incyte and MorphoSys to Host Investor Event to Discuss the Unmet Need and Global Opportunities for Tafasitamab in Non-Hodgkin Lymphomas
12:00am, Thursday, 17'th Sep 2020
Incyte and MorphoSys to Host Investor Event to Discuss the Unmet Need and Global Opportunities for Tafasitamab in Non-Hodgkin Lymphomas
Lilly and Pfizer Are Testing Treatments for Hospitalized Covid Patients
05:57pm, Wednesday, 16'th Sep 2020
Lilly’s anti-inflammatory drug Olumiant reduced hospital stays when combined with Gilead’s remdesivir.
Bank of America Corp DE Reduces Position in Incyte Co. (NASDAQ:INCY)
07:03am, Wednesday, 16'th Sep 2020
Bank of America Corp DE lessened its holdings in shares of Incyte Co. (NASDAQ:INCY) by 2.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission
Coronavirus update: WHO says record number of new cases — 307,930 — counted worldwide on Sunday
05:31pm, Monday, 14'th Sep 2020
The World Health Organization said a record number of cases of the coronavirus that causes COVID-19 were recorded on Sunday around the world for a total of...
Eli Lilly Arthritis Drug Helped Hospitalized Covid-19 Patients Recover Faster
03:12pm, Monday, 14'th Sep 2020
Eli Lilly is seeking emergency-use authorization for the arthritis drug Olumiant after a study found it accelerated the recovery of hospitalized Covid-19 patients who were also treated with Gilead’s
Shares of Lilly and Incyte gain after late-stage study finds their arthritis drug can help reduce COVID-19 recovery time
11:48am, Monday, 14'th Sep 2020
Eli Lily & Co. undefined and Incyte Corp. undefined said Monday that their rheumatoid arthritis drug Olumiant helped reduce recovery time in hospitalized...
Shares of Lilly and Incyte gain after late-stage study finds their arthritis drug can help reduce COVID-19 recovery time
07:48am, Monday, 14'th Sep 2020
Eli Lily & Co. LLY, +1.27% and Incyte Corp. INCY, -0.29% said Monday that their rheumatoid arthritis drug Olumiant helped reduce recovery time in hospitalized COVID-19 patients when it was used in com
Biotechs With Strong Balance Sheets
12:03pm, Wednesday, 09'th Sep 2020
Not all biotechs are created equal. Strong balance sheets can separate the weak from the strong.
